{
    "id": 29617,
    "fullName": "ARAF P216A",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "ARAF P216A does not lie within any known functional domains of the Araf protein (UniProt.org). P216A has been identified in the scientific literature (PMID: 30867592), but has not been biochemically characterized and therefore, its effect on Araf protein function is unknown (PubMed, Oct 2019).",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 14632,
                    "pubMedId": 30867592,
                    "title": "Efficacy of MEK inhibition in patients with histiocytic neoplasms.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30867592"
                },
                {
                    "id": 285,
                    "pubMedId": null,
                    "title": null,
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 369,
        "geneSymbol": "ARAF",
        "terms": [
            "ARAF",
            "A-RAF",
            "ARAF1",
            "PKS2",
            "RAFA1"
        ]
    },
    "variant": "P216A",
    "createDate": "03/28/2019",
    "updateDate": "10/07/2019",
    "referenceTranscriptCoordinates": {
        "id": 178991,
        "transcript": "NM_001654",
        "gDna": "chrX:g.47566727C>G",
        "cDna": "c.646C>G",
        "protein": "p.P216A",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 16579,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase II trial, treatment with Cotellic (cobimetinib) in patients with histiocytic neoplasms resulted in a PET overall response rate of 89% (16/18), with complete response in 72% (13/18) and partial response in 17% (3/18), and resulted in stable disease in 6% (1/18) of patients, including a complete response in a patient with Erdheim-Chester disease harboring KRAS G12R and ARAF P216A (PMID: 30867592; NCT01953926).",
            "molecularProfile": {
                "id": 31702,
                "profileName": "ARAF P216A KRAS G12R"
            },
            "therapy": {
                "id": 1004,
                "therapyName": "Cobimetinib",
                "synonyms": null
            },
            "indication": {
                "id": 60073,
                "name": "lymphatic system cancer",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 14632,
                    "pubMedId": 30867592,
                    "title": "Efficacy of MEK inhibition in patients with histiocytic neoplasms.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30867592"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 31690,
            "profileName": "ARAF P216A",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 31702,
            "profileName": "ARAF P216A KRAS G12R",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 178992,
            "transcript": "XM_011543908",
            "gDna": "chrX:g.47566727C>G",
            "cDna": "c.646C>G",
            "protein": "p.P216A",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 178991,
            "transcript": "NM_001654",
            "gDna": "chrX:g.47566727C>G",
            "cDna": "c.646C>G",
            "protein": "p.P216A",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}